Literature DB >> 20019032

Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.

T A Ashfield1, H E Syddall, H J Martin, E M Dennison, C Cooper, A Aihie Sayer.   

Abstract

BACKGROUND: reduced grip strength is associated with adverse health consequences, and there is interest in identifying modifiable influences. Cardiovascular drugs are commonly used by older people, but their effect on muscle strength is unclear.
METHODS: we investigated associations between cardiovascular drug use and grip strength among 1,572 men and 1,415 women, aged 59-73, who participated in the Hertfordshire Cohort Study.
RESULTS: Forty-five percent of participants were taking a cardiovascular drug. Furosemide was associated with average decreases in grip strength of 3.15 kg (95% confidence interval [CI] 0.90, 5.39, P < 0.01) among men and 2.35 kg (95% CI 0.93, 3.77, P < 0.01) among women after adjustment for age and height. Corresponding differences for nitrates were 1.84 kg (95% CI 0.29, 3.39, P = 0.02) among men and 3.66 kg (95% CI 1.99, 5.33, P < 0.01) among women. Calcium channel blockers and fibrates were associated with reduced grip among women. Statins were not associated with grip. The associations between grip strength and nitrate use in men and nitrate and fibrate use in women were robust to additional adjustment for co-morbidity.
CONCLUSIONS: use of some cardiovascular drugs is associated with reduced grip strength in older people. These findings have potential implications for the functional ability of older people treated with these drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019032      PMCID: PMC3546312          DOI: 10.1093/ageing/afp203

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  30 in total

1.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

Authors:  Richard C Pasternak; Sidney C Smith; C Noel Bairey-Merz; Scott M Grundy; James I Cleeman; Claude Lenfant
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

2.  Escalating polypharmacy.

Authors:  D A Gorard
Journal:  QJM       Date:  2006-10-09

Review 3.  Physiology of nitric oxide in skeletal muscle.

Authors:  J S Stamler; G Meissner
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

4.  Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study.

Authors:  Avan Aihie Sayer; Holly E Syddall; Helen J Martin; Elaine M Dennison; Helen C Roberts; Cyrus Cooper
Journal:  Age Ageing       Date:  2006-05-11       Impact factor: 10.668

5.  Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study.

Authors:  J Sirola; T Rikkonen; M Tuppurainen; J S Jurvelin; H Kröger
Journal:  Calcif Tissue Int       Date:  2006-04-13       Impact factor: 4.333

6.  The influence of bumetanide on the membrane potential of mouse skeletal muscle cells in isotonic and hypertonic media.

Authors:  H G van Mil; R J Geukes Foppen; J Siegenbeek van Heukelom
Journal:  Br J Pharmacol       Date:  1997-01       Impact factor: 8.739

7.  Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial.

Authors:  Deepa Sumukadas; Miles D Witham; Allan D Struthers; Marion E T McMurdo
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

8.  Statin therapy, muscle function and falls risk in community-dwelling older adults.

Authors:  D Scott; L Blizzard; J Fell; G Jones
Journal:  QJM       Date:  2009-07-24

9.  Symptomatic hypomagnesemia in children.

Authors:  Y K Tsau; W Y Tsai; F L Lu; W S Tsai; C H Chen
Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi       Date:  1998 Nov-Dec

10.  Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults.

Authors:  Joseph V Agostini; Mary E Tinetti; Ling Han; Gail McAvay; Joanne M Foody; John Concato
Journal:  J Am Geriatr Soc       Date:  2007-03       Impact factor: 5.562

View more
  13 in total

Review 1.  Selecting Potential Pharmacological Interventions in Sarcopenia.

Authors:  Amanda J Kilsby; Avan A Sayer; Miles D Witham
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

2.  Skeletal muscle ultrastructure and function in statin-tolerant individuals.

Authors:  Jason L Rengo; Damien M Callahan; Patrick D Savage; Philip A Ades; Michael J Toth
Journal:  Muscle Nerve       Date:  2015-12-09       Impact factor: 3.217

3.  Associations Between Statin Use and Physical Function in Older Adults from The Netherlands and Australia: Longitudinal Aging Study Amsterdam and Australian Longitudinal Study on Women's Health.

Authors:  Laurette van Boheemen; Susan E Tett; Evelien Sohl; Jacqueline G Hugtenburg; Natasja M van Schoor; G M E E Peeters
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

4.  Antihypertensive and Statin Medication Use and Motor Function in Community-Dwelling Older Adults.

Authors:  Amichai Perlman; Raj C Shah; David A Bennett; Aron S Buchman; Ilan Matok
Journal:  J Am Med Dir Assoc       Date:  2015-11-17       Impact factor: 4.669

5.  The epidemiology of sarcopenia in community living older adults: what role does lifestyle play?

Authors:  David Scott; Leigh Blizzard; James Fell; Graeme Jones
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-07-28       Impact factor: 12.910

6.  Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment.

Authors:  William M Southern; Anna S Nichenko; Daniel D Shill; Corey C Spencer; Nathan T Jenkins; Kevin K McCully; Jarrod A Call
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

7.  Associations of Grip Strength and Change in Grip Strength With All-Cause and Cardiovascular Mortality in a European Older Population.

Authors:  Orawan Prasitsiriphon; Wiraporn Pothisiri
Journal:  Clin Med Insights Cardiol       Date:  2018-04-20

Review 8.  New horizons in the pathogenesis, diagnosis and management of sarcopenia.

Authors:  Avan Aihie Sayer; Sian M Robinson; Harnish P Patel; Tea Shavlakadze; Cyrus Cooper; Miranda D Grounds
Journal:  Age Ageing       Date:  2013-01-11       Impact factor: 10.668

Review 9.  Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.

Authors:  Ana Filipa Macedo; Fiona Claire Taylor; Juan P Casas; Alma Adler; David Prieto-Merino; Shah Ebrahim
Journal:  BMC Med       Date:  2014-03-22       Impact factor: 8.775

Review 10.  Physical activity in older age: perspectives for healthy ageing and frailty.

Authors:  Jamie S McPhee; David P French; Dean Jackson; James Nazroo; Neil Pendleton; Hans Degens
Journal:  Biogerontology       Date:  2016-03-02       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.